| Literature DB >> 33987784 |
Eileen Wang1, Chloe Getrajdman2, Gabriela Frid1, Japjot Bal1, Cynthia Abraham3, Adam Jacobs3, Yasmin Meah3, Farida Nentin1,3.
Abstract
The East Harlem Health Outreach Partnership (EHHOP) is a medical student-run and attending-supervised clinic that provides primary care to predominantly Spanish-speaking, uninsured patients living in East Harlem, New York. In 2010, the clinic launched a Women's Health Clinic (WHC), to offer comprehensive gynecologic and reproductive healthcare under the guidance of faculty gynecologists. In this cross-sectional study, we analyzed WHC data from January 2018 to March 2021. Over this period, 59 individual patients were seen over 39 clinical sessions through a total of 164 clinical encounters staffed by 43 medical students and 19 faculty preceptors from the Department of Obstetrics and Gynecology at Mount Sinai. The most common reasons for referral to the EHHOP WHC were abnormal uterine bleeding, contraception counseling, and management of abnormal Pap smears; the most common procedures performed were Pap smears, long-acting reversible contraception placements and removals, and colposcopies. We discuss the critical role that student-run, physician-supervised reproductive health clinics play in reducing disparities in gynecologic care for uninsured women.Entities:
Keywords: Free clinic; Gynecology clinic; Reproductive health; Student-run clinic; Uninsured
Mesh:
Year: 2021 PMID: 33987784 PMCID: PMC8118096 DOI: 10.1007/s10900-021-01001-3
Source DB: PubMed Journal: J Community Health ISSN: 0094-5145
Patient and clinic demographics
| Patient characteristic (n = 59) | |
|---|---|
| Agea | 41 (37–48.5) |
| BMIa | 30.4 (26.4–34.1) |
| Obesityb (%) | 31 (52.5) |
| Number of completed visits per patienta | 2 (1–4) |
| Number of scheduled visits per patienta | 3 (1.5–4) |
| Ethnicity (%) | |
| Hispanic | 57 (96.6) |
| Non-Hispanic | 2 (3.4) |
| Nationality (%) | |
| Mexican | 45 (76.3) |
| Ecuadorian | 6 (10.2) |
| Dominican | 3 (5.1) |
| Guatemalan | 1 (1.7) |
| French | 1 (1.7) |
| Guyanese | 1 (1.7) |
| Brazilian | 1 (1.7) |
| Puerto rican | 1 (1.7) |
| Primary language (%) | |
| Spanish | 54 (91.5) |
| English | 5 (8.5) |
| Graviditya | 4 (3–5) |
| Prior full term deliveriesa | 3 (2–3) |
| Prior preterm deliveriesa | 0 (0–0) |
| Prior miscarriages or abortionsa | 1 (0–1) |
| Living childrena | 3 (2–3.5) |
| Medical History (%) | |
| Anxiety/Depression/PTSD | 27 (45.8) |
| Pre-Diabetes | 15 (25.4) |
| Diabetes | 12 (20.3) |
| Hypertension | 7 (11.9) |
| Hyperlipidemia | 8 (13.6) |
| Asthma | 7 (11.9) |
| Autoimmune disease | 6 (10.2) |
| Non-alcoholic fatty liver disease | 5 (8.5) |
| Chronic kidney disease | 2 (3.4) |
| Substance use disorder | 1 (1.2) |
| History of cancer | 1 (1.2) |
| Kallman’s syndrome | 1 (1.2) |
| Coronary artery disease | 1 (1.2) |
| History of intimate partner violence (%) | 19 (32.2) |
| Previously or currently followed by EHHOP mental health clinic | 23 (39.0) |
aData reported as median, IQR
bDefined as BMI ≥ 30.0
Gynecologic needs addressed per clinical encounter
| Gynecologic Needs (n = 164 clinical encounters) | |
|---|---|
| Abnormal uterine bleeding (AUB) (%) | 72 (43.9) |
| Heavy Menstrual Bleeding | 39 (54.2) |
| Ovulatory Dysfunction | 19 (26.4) |
| Post-Coital Bleeding | 8 (11.1) |
| Post-Menopausal Bleeding | 6 (8.3) |
| Contraception Counseling (%) | 64 (39.0) |
| Abdominal Pain/Pelvic Pain/Dyspareunia (%) | 58 (35.4) |
| Abnormal Pap smear management (%) | 52 (31.7) |
| Vaginal Discharge/Pruritis (%) | 23 (14.0) |
| Breast Symptoms (%) | 21 (12.8) |
| Pain | 14 (66.7) |
| Discharge | 3 (14.3) |
| Lump/Mass | 4 (19.0) |
| Menopause Symptoms/Counseling (%) | 11 (6.7) |
| Vaginal/Vulvar Lesions (%) | 11 (6.7) |
| Intimate Partner Violence (%) | 11 (6.7) |
| History of Ovarian Cysts (%) | 9 (5.5) |
| Preconception Counseling/Infertility (%) | 9 (5.5) |
| Urinary Symptoms (%) | 40 (24.4) |
| History of Fibroids (%) | 3 (1.8) |
| LEEP Counseling (%) | 3 (1.8) |
| Gynecologic Imaging Results Reviewed (%) | 3 (1.8) |
| Recent Miscarriage/Abortion Counseling (%) | 2 (1.2) |
Gynecologic services provided by clinical encounter
| Gynecologic Services (n = 164 clinical encounters) | |
|---|---|
| Pap smears (%) | 60 (36.6) |
| IUD Placement (%) | 15 (9.1) |
| IUD Removal (%) | 11 (6.7) |
| IUD String Check (%) | 12 (7.3) |
| Nexplanon Placement (%) | 4 (2.4) |
| Nexplanon Removal (%) | 6 (3.7) |
| Endometrial Biopsy (%) | 15 (9.1) |
| Colposcopy (%) | 16 (9.8) |
| Point-of-care TVUS (%) | 8 (4.9) |
| Vulvar biopsy (%) | 1 (0.6) |
| Trichloroacetic acid treatment (%) | 4 (2.4) |
| Sexually Transmitted Infection (STI) Testing (%) | 83 (50.6) |
| Gonorrhea/Chlamydia | 71 |
| HIV | 44 |
| Hepatitis C | 40 |
| Hepatitis B | 31 |
| Syphilis | 35 |
| Vaginitis Testing (%) | 13 (7.9) |
| Candida | 6 |
| Bacterial Vaginosis | 7 |
| Trichomonas | 11 |
| Group B Strep | 1 |
| Urinalysis (%) | 26 (15.9) |
| Hormonal Testing (including fertility assessment) (%) | 11 (6.7) |
| Depo Provera Administered (%) | 8 (4.9) |
| Hepatitis B Vaccine Administered (%) | 11 (6.7) |
| Influenza Vaccine Administered (%) | 5 (3.0) |
Visit outcomes by patient encounter
| Gynecologic outcomes | |
|---|---|
| Pap smear HPV resultsa (%) | |
| Positive | 14 (25.5) |
| Negative | 41 (74.5) |
| Pap smear cytology results (%) | |
| NILM | 33 (55.0) |
| ASCUS | 9 (15.0) |
| ASC-H | 3 (5.0) |
| LSIL | 2 (3.3) |
| HSIL | 1 (1.7) |
| AGC | 1 (1.7) |
| Insufficient sample/Sample unable to be process/Sample lost | 11 (18.3) |
| Endometrial biopsy result (%) | |
| Benign/unremarkable | 11 (73.3) |
| Endometrial polyp | 3 (20.0) |
| Chronic endometritis | 1 (6.7) |
| Colposcopy results (%) | |
| No biopsies performed | 2 (12.5) |
| Negative for CIN | 3 (18.8) |
| CIN1 | 11 (68.8) |
| Vaginitis testing positive results (% positive) | |
| Candida | 0 (0) |
| Bacterial vaginosis | 2 (20) |
| Trichomonas | 0 (0) |
| Group B Strep | 0 (0) |
| Vulvar biopsy result | |
| HPV condyloma (HPV 43) | 1 (100) |
| STI testing positive results (% positive) | |
| Chlamydia | 2 (2.8) |
| Gonorrhea | 0 (0) |
| HIV | 0 (0) |
| Hepatitis C | 0 (0) |
| Hepatitis B | 1 (3.2) |
| Syphilis | 0 (0) |
| Urinalysis positive for urinary tract infection (% positive) | 4 (15.4 %) |
| PCOS diagnosis made (%) | 2 (66 %) |
| Encounters during which medications were prescribed (%) | 51 (31.1) |
| Types of medications prescribed | |
| Antibiotics | 20 |
| Anti-fungal (Candidiasis) | 9 |
| Azithromycin (Chlamydia) | 2 |
| Metronidazole (Bacterial vaginosis) | 2 |
| Doxycycline (Chronic endometritis) | 1 |
| Nitrofurantoin/TMP-SMX (Urinary tract infection) | 6 |
| Oral progesterone | 9 |
| Norethisterone | 3 |
| Medroxyprogesterone | 6 |
| Combined oral contraception | 5 |
| Vaginal estrogen cream/Lubrication | 9 |
| Lactobacillus probiotic | 2 |
| Prenatal vitamins | 2 |
| Clomiphene citrate | 1 |
a Among those Pap smears in which co-testing was performed and result obtained